These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19429119)

  • 1. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells.
    Greco SJ; Sarkar S; Casadesus G; Zhu X; Smith MA; Ashford JW; Johnston JM; Tezapsidis N
    Neurosci Lett; 2009 May; 455(3):191-4. PubMed ID: 19429119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells.
    Greco SJ; Sarkar S; Johnston JM; Tezapsidis N
    Biochem Biophys Res Commun; 2009 Feb; 380(1):98-104. PubMed ID: 19166821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells.
    Greco SJ; Sarkar S; Johnston JM; Zhu X; Su B; Casadesus G; Ashford JW; Smith MA; Tezapsidis N
    Biochem Biophys Res Commun; 2008 Nov; 376(3):536-41. PubMed ID: 18801339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
    Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
    Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
    Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J
    Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.
    Sang H; Lu Z; Li Y; Ru B; Wang W; Chen J
    Neurosci Lett; 2001 Oct; 312(3):141-4. PubMed ID: 11602330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
    Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
    J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective loss of basal forebrain cholinergic neurons by 192 IgG-saporin is associated with decreased phosphorylation of Ser glycogen synthase kinase-3beta.
    Hawkes C; Jhamandas JH; Kar S
    J Neurochem; 2005 Oct; 95(1):263-72. PubMed ID: 16181430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation.
    Resende R; Ferreiro E; Pereira C; Oliveira CR
    J Neurosci Res; 2008 Jul; 86(9):2091-9. PubMed ID: 18335524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
    Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
    Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
    Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
    Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.
    Mercado-Gómez O; Hernández-Fonseca K; Villavicencio-Queijeiro A; Massieu L; Chimal-Monroy J; Arias C
    Neurochem Res; 2008 Aug; 33(8):1599-609. PubMed ID: 18461448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β.
    Amin J; Paquet C; Baker A; Asuni AA; Love S; Holmes C; Hugon J; Nicoll JA; Boche D
    Neuropathol Appl Neurobiol; 2015 Jun; 41(4):445-57. PubMed ID: 25486988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.